Dexamethasone 0.5 mg per 5 mL Oral Elixir: Swish and Spit
Dexamethasone 0.5 mg per 5 mL oral elixir should be used as a mouth rinse with swish and spit technique, not swallowed. This is the standard administration method for topical corticosteroid mouthwashes used to manage oral mucositis and stomatitis.
Rationale Based on Guidelines and Evidence
The most recent expert consensus on oral mucositis management (2025) explicitly states that dexamethasone mouth rinse (0.1 mg/mL) should be used for topical application when treating ulcers in multiple locations or difficult-to-reach areas of the oral cavity 1. The ESMO clinical practice guidelines (2015) similarly recommend that dexamethasone mouth rinse (0.1 mg/mL) should be used topically for treating stomatitis, with the standard instruction to rinse and spit 2.
Concentration Context
Your formulation at 0.5 mg per 5 mL equals 0.1 mg/mL, which is the exact concentration recommended in guidelines for topical oral use 1, 2. This is not a coincidence—this concentration is specifically designed for local anti-inflammatory action on oral mucosa, not systemic absorption.
Standard Administration Protocol
Based on guideline recommendations and recent research:
- Volume: 10 mL per rinse for adults 3, 4
- Technique: Swish for 1-2 minutes, then spit out 1, 5
- Frequency: 4 times daily 3, 4
- Timing: After meals and at bedtime is optimal 2
- Post-rinse: Avoid eating or drinking for 15-30 minutes afterward 1, 2
For pediatric patients under 5 years, use 5 mL twice daily with swish and spit technique 3.
Why Not Swallow?
The FDA labeling for dexamethasone clearly distinguishes between systemic administration (oral tablets, IV/IM injection with doses of 0.5-9 mg daily for systemic effects) and topical application 6. When dexamethasone is intended for systemic use, it is given as tablets or injection—not as a dilute oral rinse.
Swallowing this formulation would provide minimal systemic benefit while potentially increasing systemic corticosteroid side effects without achieving adequate local anti-inflammatory concentration on the oral mucosa where it's needed. The therapeutic goal is direct contact with inflamed oral tissues, not systemic absorption.
Clinical Evidence Supporting Swish and Spit
Multiple recent studies confirm the swish-and-spit approach:
- A 2020 prospective study demonstrated effectiveness of dexamethasone mouthwash using swish-and-expectorate technique for both prophylaxis and treatment of stomatitis 7
- A 2019 randomized phase II trial instructed patients to "swish/expectorate 10 mL" of steroid-containing rinse 5
- A 2025 physicochemical stability study specifically recommended "10 mL (swish and spit) four times daily" for the 0.1 mg/mL formulation 3
Common Pitfall to Avoid
Do not confuse this topical oral formulation with systemic dexamethasone therapy. The concentration (0.1 mg/mL) and volume (10 mL = 1 mg total per rinse) are far too low for systemic therapeutic effect but ideal for topical anti-inflammatory action on oral mucosa. Instructing patients to swallow would be both ineffective for the intended purpose and potentially expose them to unnecessary systemic steroid effects over time.